Cyclacel Pharmaceuticals Inc (CYCC) — Cash Flow Quality Index
Latest as of June 2013:
-3.56x
Cyclacel Pharmaceuticals Inc (CYCC) has a Cash Flow Quality Index of -3.56x as of June 2013. Operating cash flow of $-5.31 Million is below net income of $1.49 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Cyclacel Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-3.56x
Operating CF / Net Income
Operating Cash Flow
$-5.31 Million
USD
Net Income
$1.49 Million
USD
Data as of
Jun 2013
Most recent filing
Annual Cash Flow Quality Index for Cyclacel Pharmaceuticals Inc (None–None)
Year-by-year earnings quality comparison for Cyclacel Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.